PMID- 36597355 OWN - NLM STAT- MEDLINE DCOM- 20230321 LR - 20230322 IS - 1557-7716 (Electronic) IS - 1523-0864 (Linking) VI - 38 IP - 7-9 DP - 2023 Mar TI - Nuclear Factor Erythroid 2-Related Factor 2 and Its Targets in Skeletal Muscle Repair and Regeneration. PG - 619-642 LID - 10.1089/ars.2022.0208 [doi] AB - Significance: Skeletal muscles have a robust regenerative capacity in response to acute and chronic injuries. Muscle repair and redox homeostasis are intimately linked; increased generation of reactive oxygen species leads to cellular dysfunction and contributes to muscle wasting and progression of muscle diseases. In exemplary muscle disease, Duchenne muscular dystrophy (DMD), caused by mutations in the DMD gene that encodes the muscle structural protein dystrophin, the regeneration machinery is severely compromised, while oxidative stress contributes to the progression of the disease. The nuclear factor erythroid 2-related factor 2 (NRF2) and its target genes, including heme oxygenase-1 (HO-1), provide protective mechanisms against oxidative insults. Recent Advances: Relevant advances have been evolving in recent years in understanding the mechanisms by which NRF2 regulates processes that contribute to effective muscle regeneration. To this end, pathways related to muscle satellite cell differentiation, oxidative stress, mitochondrial metabolism, inflammation, fibrosis, and angiogenesis have been studied. The regulatory role of NRF2 in skeletal muscle ferroptosis has been also suggested. Animal studies have shown that NRF2 pathway activation can stop or reverse skeletal muscle pathology, especially when endogenous stress defence mechanisms are imbalanced. Critical Issues: Despite the growing recognition of NRF2 as a factor that regulates various aspects of muscle regeneration, the mechanistic impact on muscle pathology in various models of muscle injury remains imprecise. Future Directions: Further studies are necessary to fully uncover the role of NRF2 in muscle regeneration, both in physiological and pathological conditions, and to investigate the possibilities for development of new therapeutic modalities. Antioxid. Redox Signal. 38, 619-642. FAU - Loboda, Agnieszka AU - Loboda A AUID- ORCID: 0000-0003-3523-3560 AD - Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, Krakow, Poland. FAU - Dulak, Jozef AU - Dulak J AD - Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, Krakow, Poland. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20230302 PL - United States TA - Antioxid Redox Signal JT - Antioxidants & redox signaling JID - 100888899 RN - 0 (NF-E2-Related Factor 2) SB - IM MH - Animals MH - *NF-E2-Related Factor 2/genetics/metabolism MH - Signal Transduction/physiology MH - Muscle, Skeletal/metabolism MH - *Muscular Dystrophy, Duchenne/genetics/pathology MH - Regeneration/physiology OTO - NOTNLM OT - Duchenne muscular dystrophy OT - NRF2 OT - heme oxygenase-1 OT - microRNAs OT - muscle regeneration OT - oxidative stress EDAT- 2023/01/05 06:00 MHDA- 2023/03/22 06:00 CRDT- 2023/01/04 01:33 PHST- 2023/01/05 06:00 [pubmed] PHST- 2023/03/22 06:00 [medline] PHST- 2023/01/04 01:33 [entrez] AID - 10.1089/ars.2022.0208 [doi] PST - ppublish SO - Antioxid Redox Signal. 2023 Mar;38(7-9):619-642. doi: 10.1089/ars.2022.0208. Epub 2023 Mar 2.